About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Florida | 9,710 Studies Near You | Clareo Health

Clinical Trials LocationsFlorida

Clinical Trials in Florida

Discover 9,710 clinical trials near Florida. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 9381-9400 of 9,710 trials

TERMINATEDPhase 2/325 miles

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

NCT00664183

The purpose of this study is to determine the safety and efficacy of Vitreosolve in diabetic retinopathy patients.

Diabetic Retinopathy

Vitreoretinal Technologies, Inc.400 participantsStarted Mar 2008

Phoenix, Arizona, United States • Beverly Hills, California, United States • Santa Ana, California, United States +14 more locations

COMPLETEDPhase 341 miles

Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee

NCT00722852

The purpose of this study is to provide replicated evidence of safety and efficacy of 100 mg ketoprofen in Diractin®.

Osteoarthritis of the Knee

IDEA AG555 participantsStarted Jun 2008

Phoenix, Arizona, United States • Tempe, Arizona, United States • Tucson, Arizona, United States +34 more locations

Find Trials by Condition in Florida

Breast Cancerin Florida Lung Cancerin Florida Prostate Cancerin Florida Colorectal Cancerin Florida Melanomain Florida Leukemiain Florida Lymphomain Florida Pancreatic Cancerin Florida Ovarian Cancerin Florida Brain Cancerin Florida Diabetes

Data from ClinicalTrials.govTerms

COMPLETEDPhase 2/341 miles

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199

To evaluate the effect of 6-month administration of CP-945,598 on: * weight loss and waist circumference, * blood pressure, cholesterol, glucose * other biochemical variables like insulin, leptin, ghrelin, adiponectin, PAI 1, TNF-Î± and hsCRP * the relationship between the concentration of the drug on the blood and the above parameters * physical and psychosocial functioning, weight related symptoms, treatment satisfaction, appetite/hunger/satiety/craving and mood, anxiety, anhedonia and depression

Pfizer282 participantsStarted Mar 2005

Clearwater, Florida, United States • Kissimmee, Florida, United States • Orlando, Florida, United States +12 more locations

COMPLETEDPhase 249 miles

A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain

NCT00394563

The purpose of this study is to look at the effects of RN624 on moderate to severe knee pain due to osteoarthritis. This study will look at the safety and pain relieving effects of RN624 compared to placebo over a 4 month period.

Pfizer450 participantsStarted Mar 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +45 more locations

COMPLETEDPhase 157 miles

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

NCT00645021

CP-945,598 is eliminated following extensive metabolism. Decrease hepatic function can affect its elimination from the body via metabolism. This study will therefore compare the pharmacokinetics (time course of drug concentrations in the body), safety, and tolerability of CP-945,598 in patients with mild and moderate hepatic impairment and healthy control subjects.

ObesityHepatic Insufficiency

Pfizer24 participantsStarted Apr 2008

Miami, Florida, United States • Orlando, Florida, United States

COMPLETEDPhase 257 miles

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

NCT00141661

A 10-week safety and tolerability study of a potential treatment for mild to moderate Alzheimer's disease.

Alzheimer Disease

Pfizer67 participantsStarted Oct 2005

Sun City, Arizona, United States • Fresno, California, United States • San Diego, California, United States +9 more locations

UNKNOWNPhase 257 miles

Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia

NCT00813826

The purpose of this study is to evaluate the efficacy and safety of SLC022 in treating pain associated with post-herpetic neuralgia (PHN) in recently diagnosed patients.

Postherpetic Neuralgia

Solace Pharmaceuticals204 participantsStarted Jan 2009

Sierra Vista, Arizona, United States • Mission Viejo, California, United States • Orlando, Florida, United States +16 more locations

COMPLETEDNA57 miles

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women

NCT00932516

The purpose of this study is to examine the effectiveness of the South Beach Diet™ and South Beach Diet™ products compared to a traditional calorie restricted diet.

Mondelēz International, Inc.248 participantsStarted Mar 2007

Northridge, California, United States • Bradenton, Florida, United States • Miami, Florida, United States +1 more locations

COMPLETEDPhase 261 miles

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

NCT00481520

The primary purpose of the study is to assess whether SAM-531, an investigational drug, is safe and well tolerated, compared with placebo (a medically inactive substance), in subjects with mild to moderate Alzheimer's disease.

Alzheimer Disease

Wyeth is now a wholly owned subsidiary of Pfizer72 participantsStarted Jun 2007

Delray Beach, Florida, United States • Hallandale, Florida, United States • St. Petersburg, Florida, United States +4 more locations

COMPLETEDPhase 361 miles

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

NCT00220766

The objective of this study is to determine if the safety and tolerability of Immune Globulin Intravenous (Human), 10% caprylate/chromatography (IGIV-C)purified is similar when infused at two different infusion rates. The primary objective is to compare the incidence and severity of all infusion related adverse events when IGIV-C, 10% is administered at a rate of 0.14 mL/kg/min compared to a rate of 0.08 mL/kg/min after a single daily infusion.

Immunologic Deficiency SyndromeAgammaglobulinemiaSevere Combined Immunodeficiency+2 more

Grifols Therapeutics LLC100 participantsStarted Aug 2002

Birmingham, Alabama, United States • Denver, Colorado, United States • Washington D.C., District of Columbia, United States +10 more locations

COMPLETEDPhase 368 miles

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

NCT00630877

The primary purpose of this study was to evaluate the psychometric characteristics (reliability, validity, and responsiveness) of a Flushing ASsessment Tool (FAST) in subjects receiving niacin extended-release (NER) plus aspirin (ASA) daily for 6 weeks. The FAST is a questionnaire that was developed to provide a detailed assessment of flushing symptoms and their impact in patients receiving niacin therapy. The effect of aspirin on flushing symptoms, as measured by the FAST, was also evaluated.

Abbott276 participantsStarted Feb 2008

Birmingham, Alabama, United States • Anaheim, California, United States • Walnut Creek, California, United States +37 more locations

COMPLETEDPhase 380 miles

Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain

NCT00433290

The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.

Osteoarthritis Knee Pain

Eli Lilly and Company256 participantsStarted Feb 2007

Fort Myers, Florida, United States • Edison, New Jersey, United States • Lake Jackson, Texas, United States +4 more locations

COMPLETEDPhase 380 miles

Duloxetine Versus Placebo for Osteoarthritis Knee Pain

NCT00408421

The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.

Osteoarthritis Knee Pain

Eli Lilly and Company231 participantsStarted Nov 2006

Chandler, Arizona, United States • Beverly Hills, California, United States • Northridge, California, United States +24 more locations

COMPLETEDPhase 2124 miles

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00104273

The purpose of this study is to evaluate the safety, tolerability, and efficacy of two dose levels of rasagiline mesylate versus placebo in patients with mild-to-moderate Alzheimer's Disease who are taking Aricept.

DementiaAlzheimer's Disease

Teva Branded Pharmaceutical Products R&D, Inc.376 participantsStarted Aug 2004

Huntsville, Alabama, United States • Huntsville, Alabama, United States • Tucson, Arizona, United States +55 more locations

TERMINATEDPhase 2139 miles

Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease

NCT00021723

A multi-center, double-blind, placebo-controlled out-patient, safety, tolerability, and pilot efficacy study of intramuscular AN-1792 in patients with mild to moderate Alzheimer's disease.

Alzheimer's Disease

JANSSEN Alzheimer Immunotherapy Research & Development, LLC375 participantsStarted Sep 2001

Peoria, Arizona, United States • Phoenix, Arizona, United States • Beverly Hills, California, United States +8 more locations

UNKNOWNPhase 4139 miles

Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer

NCT00484614

Women with newly diagnosed breast cancer anticipating breast-conserving surgery are enrolled into the study and will undergo both high-resolution positron emission mammographic (PEM) imaging and contrast-enhanced magnetic resonance imaging (MRI) of the breast(s). The purpose of this study is to determine changes in surgical management resulting from PEM or MRI imaging as compared to conventional imaging and to determine if the changes were appropriate with histopathology as gold standard.

Naviscan PET Systems472 participantsStarted Sep 2006

Los Angeles, California, United States • San Diego, California, United States • Boca Raton, Florida, United States +3 more locations

COMPLETEDPhase 2152 miles

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

NCT00325962

The purpose of this study is to determine whether 6R-BH4 (sapropterin dihydrochloride) is safe and effective in the treatment of poorly controlled hypertension in the presence or absence of type 2 diabetes.

BioMarin Pharmaceutical84 participantsStarted May 2006

Hoover, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +21 more locations

TERMINATEDPhase 1166 miles

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

NCT00637338

PF-04603629 is being investigated for the treatment of Type 2 diabetes mellitus (T2DM). Specifically, PF-04603629 is a protein that is a combination of exendin-4 (a glucagon-like peptide-1 (GLP-1) mimetic currently marketed as Byetta®) fused to human transferrin (a naturally occuring protein) in order to increase the concentration of exendin-4 in the blood. The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-04603629 following multiple escalating subcutaneous doses in adult subjects with T2DM.

Diabetes Mellitus, Type 2

Pfizer42 participantsStarted Apr 2008

Phoenix, Arizona, United States • Miami, Florida, United States • Wichita, Kansas, United States +1 more locations

COMPLETEDPhase 3177 miles

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

NCT00494013

The purpose of this study is to examine the effectiveness and safety of insulin lispro protamine suspension (ILPS) as compared to insulin detemir as basal insulin therapy in adults with type 2 diabetes. A gatekeeper strategy will be employed for sequentially testing the secondary objectives.

Diabetes Mellitus Type 2

Eli Lilly and Company442 participantsStarted Aug 2007

Hueytown, Alabama, United States • Litchfield Park, Arizona, United States • Phoenix, Arizona, United States +53 more locations

COMPLETEDPhase 4810 miles

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

NCT00418171

The primary objective of the study is to estimate the relative incidence among users of ziprasidone and olanzapine of non-suicide mortality.

Pfizer18,239 participantsStarted Feb 2002

San Bernardino, California, United States • ‘Aiea, Hawaii, United States • Schaumburg, Illinois, United States +2 more locations

PreviousPage 470 of 486Next

in Florida

Heart Diseasein Florida